Search

everythinglearnresearchcommunity

for

Search:↓

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Adalimumab improved folliculitis decalvans in most patients.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

RCS-01 is safe and may help rejuvenate aging skin.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Scientists made a sensor that can detect a specific type of RNA related to androgen receptors quickly and accurately.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Blocking certain immune signals can reduce skin damage from radiation therapy.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Etanercept effectively treated a severe skin condition when other treatments failed.

Calancardin B may help reduce inflammation in immune cells.